Immunocore Holdings (IMCR) Current Assets (2022 - 2025)
Historic Current Assets for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $1.0 billion.
- Immunocore Holdings' Current Assets rose 168.44% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 168.44%. This contributed to the annual value of $929.9 million for FY2024, which is 7583.75% up from last year.
- Per Immunocore Holdings' latest filing, its Current Assets stood at $1.0 billion for Q3 2025, which was up 168.44% from $1.0 billion recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Current Assets ranged from a high of $1.0 billion in Q3 2025 and a low of $474.0 million during Q4 2022
- Its 4-year average for Current Assets is $866.1 million, with a median of $948.6 million in 2025.
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 7583.75% in 2024, then skyrocketed by 168.44% in 2025.
- Immunocore Holdings' Current Assets (Quarter) stood at $474.0 million in 2022, then increased by 11.57% to $528.8 million in 2023, then surged by 75.84% to $929.9 million in 2024, then increased by 10.0% to $1.0 billion in 2025.
- Its Current Assets stands at $1.0 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $948.6 million for Q1 2025.